Overview
- 37 inspections across 36 sites are on record.
- 131 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-28.
At a glance
Inspections
37
Sites
36
Observations
131
Career since
May 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pacific Science LLC | 28 May 2026 | Human Drugs | View 483 → |
| Cardinal Health 414 LLC | 3 Apr 2026 | Human Drugs | View 483 → |
| Cardinal Health, Inc | 21 Feb 2026 | Human Drugs | View 483 → |
| International Medication Systems Ltd. | 19 Dec 2025 | Human Drugs | View 483 → |
| NuSil Technology LLC | 14 Nov 2025 | Human Drugs |
Sites inspected
Pacific Science LLCEl Segundo, United States1 insp.
Cardinal Health 414 LLCMemphis, United States1 insp.
Cardinal Health, IncHouston, United States1 insp.
International Medication Systems Ltd.South El Monte, United States1 insp.
NuSil Technology LLCBakersfield, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Muna Algharibeh3 shared
Lisa Shin3 shared
Ngozi G Offor2 shared
Eileen A Liu2 shared
Navneet Kaur2 shared
Amir Alavi2 shared
Bryan A Galvez2 shared
Alan L Truong2 shared
Truong X Nguyen2 shared
Thuy Tram L Nguyen1 shared
Full investigator report
Get the verbatim findings behind Claudia M Perez-Kasmarski's 131 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site